XML 25 R8.htm IDEA: XBRL DOCUMENT v3.25.3
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Sep. 27, 2025
Sep. 28, 2024
Sep. 30, 2023
OPERATING ACTIVITIES      
Net income $ 565,700,000 $ 789,500,000 $ 456,000,000.0
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation 108,900,000 99,300,000 89,600,000
Amortization of acquired intangible assets 190,900,000 209,700,000 233,800,000
Stock-based compensation expense 84,300,000 82,300,000 79,600,000
Deferred income taxes and other non-cash taxes (141,600,000) (72,100,000) (109,100,000)
Intangible assets and equipment impairment charges 225,900,000 44,800,000 223,800,000
Loss on assets held-for-sale 0 0 51,700,000
Contingent consideration fair value adjustments 0 1,700,000 (14,900,000)
Other adjustments and non-cash items 43,400,000 45,900,000 28,900,000
Changes in operating assets and liabilities, excluding the effect of acquisitions and dispositions:      
Accounts receivable 7,800,000 41,000,000.0 (1,500,000)
Inventory (1,300,000) (47,400,000) (4,900,000)
Prepaid income taxes 20,100,000 (21,700,000) 17,400,000
Prepaid expenses and other assets 11,900,000 7,300,000 23,600,000
Accounts payable (11,300,000) 22,200,000 (23,000,000.0)
Accrued expenses and other liabilities (32,300,000) 73,400,000 (14,200,000)
Deferred revenue (15,300,000) 9,300,000 14,400,000
Net cash provided by operating activities 1,057,100,000 1,285,200,000 1,051,200,000
INVESTING ACTIVITIES      
Acquisition of businesses, net of cash acquired (321,500,000) (297,300,000) (5,000,000.0)
Sale of business, net of cash disposed 0 (31,300,000) 0
Purchases of available-for-sale securities (146,900,000) (267,700,000) 0
Maturities of available-for-sale securities 176,000,000.0 0 0
Capital expenditures (58,800,000) (72,400,000) (91,800,000)
Proceeds from the Department of Defense 0 0 20,500,000
Increase in equipment under customer usage agreements (78,200,000) (57,800,000) (58,400,000)
Strategic investments (35,000,000.0) (42,500,000) (10,000,000.0)
Purchase of intellectual property (15,400,000) (10,000,000.0) 0
Other activity (2,900,000) (2,000,000.0) (7,400,000)
Net cash used in investing activities (482,700,000) (781,000,000.0) (152,100,000)
FINANCING ACTIVITIES      
Proceeds from long-term debt, net of issuance costs 1,161,000,000 0 0
Repayment of long-term debt (1,197,500,000) (287,500,000) (15,000,000.0)
Payment of contingent consideration (1,100,000) (2,600,000) (7,600,000)
Payment of deferred acquisition consideration 0 0 (800,000)
Repurchases of common stock (752,900,000) (835,100,000) (474,800,000)
Net proceeds from issuance of common stock under employee stock plans 38,800,000 37,800,000 43,000,000.0
Payment of minimum tax withholdings on net share settlements of equity awards (22,200,000) (17,400,000) (24,000,000.0)
Payments under finance lease obligations (3,300,000) (3,800,000) (4,000,000.0)
Net cash used in financing activities (777,200,000) (1,108,600,000) (483,200,000)
Effect of exchange rate changes on cash and cash equivalents 2,100,000 8,900,000 300,000
Net increase (decrease) in cash and cash equivalents (200,700,000) (595,500,000) 416,200,000
Cash and cash equivalents, beginning of period [1] 2,160,200,000 2,755,700,000 2,339,500,000
Cash and cash equivalents, end of period [1] $ 1,959,500,000 $ 2,160,200,000 $ 2,755,700,000
[1] Includes $33.2 million of cash recorded in assets held-for-sale - current assets as of September 30, 2023.